Computational design of candidate multi-epitope vaccine against SARS-CoV-2 targeting structural (S and N) and non-structural (NSP3 and NSP12) proteins

References

• Adam, K. M. (2021). Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Tropical Diseases, Travel Medicine and Vaccines, 7(1), 1–13. https://doi.org/10.1186/s40794-021-00147-1
   PubMedGoogle Scholar
• Aftab, S. O., Ghouri, M. Z., Masood, M. U., Haider, Z., Khan, Z., Ahmad, A., & Munawar, N. (2020). Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. Journal of Translational Medicine, 18 (1), 1–15. https://doi.org/10.1186/s12967-020-02439-0
   PubMed Web of Science ®Google Scholar
• Ahlers, J. D., & Belyakov, I. M. (2010). Molecular pathways regulating CD4+ T cell differentiation, anergy and memory with implications for vaccines. Trends in Molecular Medicine, 16 (10), 478–491. https://doi.org/10.1016/j.molmed.2010.07.007
   PubMed Web of Science ®Google Scholar
• Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020). Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses, 12 (3), 254. https://doi.org/10.3390/v12030254
   PubMed Web of Science ®Google Scholar
• Akira, S., & Takeda, K. (2004). Toll-like receptor signalling. Nature Reviews. Immunology, 4(7), 499–511. https://doi.org/10.1038/nri1391
   PubMed Web of Science ®Google Scholar
• Antonio-Herrera, L., Badillo-Godinez, O., Medina-Contreras, O., Tepale-Segura, A., García-Lozano, A., Gutierrez-Xicotencatl, L., Soldevila, G., Esquivel-Guadarrama, F. R., Idoyaga, J., & Bonifaz, L. C. (2018). The nontoxic cholera B subunit is a potent adjuvant for intradermal DC-targeted vaccination. Frontiers in Immunology, 9, 2212. https://doi.org/10.3389/fimmu.2018.02212
   PubMed Web of Science ®Google Scholar
• Basak, S., Deb, D., Narsaria, U., Kar, T., Castiglione, F., Sanyal, I., Bade, P. D., & Srivastava, A. P. (2021). In silico designing of vaccine candidate against Clostridium difficile. Scientific Reports, 11 (1), 1–22. https://doi.org/10.1038/s41598-021-93305-6
   PubMed Web of Science ®Google Scholar
• Bayati, A., Kumar, R., Francis, V., & McPherson, P. S. (2021). SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. The Journal of Biological Chemistry, 296, 100306. https://doi.org/10.1016/j.jbc.2021.100306
   PubMed Web of Science ®Google Scholar
• Bazhan, S. I., Antonets, D. V., Karpenko, L. I., Oreshkova, S. F., Kaplina, O. N., Starostina, E. V., Dudko, S. G., Fedotova, S. A., & Ilyichev, A. A. (2019). In silico designed ebola virus T-cell multi-epitope DNA vaccine constructions are immunogenic in mice. Vaccines, 7 (2), 34. https://doi.org/10.3390/vaccines7020034
   Web of Science ®Google Scholar
• Calis, J. J., Maybeno, M., Greenbaum, J. A., Weiskopf, D., De Silva, A. D., Sette, A., Keşmir, C., & Peters, B. (2013). Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Computational Biology, 9 (10), e1003266. https://doi.org/10.1371/journal.pcbi.1003266
   PubMed Web of Science ®Google Scholar
• Carty, M., & Bowie, A. G. (2010). Recent insights into the role of Toll-like receptors in viral infection. Clinical and Experimental Immunology, 161 (3), 397–406. https://doi.org/10.1111/j.1365-2249.2010.04196.x
   PubMed Web of Science ®Google Scholar
• Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S. C., & Di Napoli, R. (2022). Features, evaluation, and treatment of coronavirus (COVID-19). StatPearls.
   Google Scholar
• Case, D. A., Darden, T. A., Cheatham, T. E., Simmerling, C. L., Wang, J., Duke, R. E., Luo, R., Crowley, M., Walker, R. C., Zhang, W., Merz, K. M., Wang, B., Hayik, S., Roitberg, A., Seabra, G., Kolossváry, I., Wong, K. F., Paesani, F., Vanicek, J. … Kollman, P. A. (2008). Amber 10 (No. BOOK). University of California.
   Google Scholar
• Castiglione, F., Mantile, F., De Berardinis, P., & Prisco, A. (2012). How the interval between prime and boost injection affects the immune response in a computational model of the immune system. Computational and Mathematical Methods in Medicine, 2012, 842329. https://doi.org/10.1155/2012/842329
   PubMed Web of Science ®Google Scholar
• Chang, C-k., Sue, S.-C., Yu, T-h., Hsieh, C.-M., Tsai, C.-K., Chiang, Y.-C., Lee, S-j., Hsiao, H-h., Wu, W.-J., & Chang, W.-L. (2006). Modular organization of SARS coronavirus nucleocapsid protein. Journal of Biomedical Science, 13 (1), 59–72. https://doi.org/10.1007/s11373-005-9035-9
   PubMed Web of Science ®Google Scholar
• Cheng, L., Zhang, X., Chen, Y., Wang, D., Zhang, D., Yan, S., Wang, H., Xiao, M., Liang, T., & Li, H. (2021). Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients. Signal Transduction and Targeted Therapy, 6 (1), 1–14. https://doi.org/10.1038/s41392-021-00718-w
   PubMed Web of Science ®Google Scholar
• Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., Chen, Z., Guo, Y., Zhang, J., Li, Y., Song, X., Chen, Y., Xia, L., Fu, L., Hou, L., … Chen, W. (2020). A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science (New York, N.Y.), 369 (6504), 650–655. https://doi.org/10.1126/science.abc6952
   PubMed Web of Science ®Google Scholar
• Cong, Y., Ulasli, M., Schepers, H., Mauthe, M., V’kovski, P., Kriegenburg, F., Thiel, V., de Haan, C. A., & Reggiori, F. (2020). Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. Journal of Virology, 94 (4), e01925-19. https://doi.org/10.1128/JVI.01925-19
   PubMed Web of Science ®Google Scholar
• Crotty, S. (2019). T follicular helper cell biology: A decade of discovery and diseases. Immunity, 50(5), 1132–1148. https://doi.org/10.1016/j.immuni.2019.04.011
   PubMed Web of Science ®Google Scholar
• Dar, H. A., Zaheer, T., Shehroz, M., Ullah, N., Naz, K., Muhammad, S. A., Zhang, T., & Ali, A. (2019). Immunoinformatics-aided design and evaluation of a potential multi-epitope vaccine against Klebsiella pneumoniae. Vaccines, 7 (3), 88. https://doi.org/10.3390/vaccines7030088
   Web of Science ®Google Scholar
• De Wit, E., Van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature reviews. Microbiology, 14(8), 523–534. https://doi.org/10.1038/nrmicro.2016.81
   PubMed Web of Science ®Google Scholar
• Deb, D., Basak, S., Kar, T., Narsaria, U., Castiglione, F., Paul, A., Pandey, A., & Srivastava, A. P. (2022). Immunoinformatics based designing a multi‐epitope vaccine against pathogenic Chandipura vesiculovirus. Journal of Cellular Biochemistry, 123 (2), 322–346. https://doi.org/10.1002/jcb.30170
   PubMed Web of Science ®Google Scholar
• Diamond, M. S., & Kanneganti, T. D. (2022). Innate immunity: The first line of defense against SARS-CoV-2. Nature Immunology, 23(2), 165–176. https://doi.org/10.1038/s41590-021-01091-0
   PubMed Web of Science ®Google Scholar
• Doherty, P. C., Allan, W., Eichelberger, M., & Carding, S. R. (1992). Roles of alphabeta and gammadelta T cell subsets in viral immunity. Annual review of Immunology, 10 (1), 123–151. https://doi.org/10.1146/annurev.iy.10.040192.001011
   PubMedGoogle Scholar
• Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8 (1), 1–7. https://doi.org/10.1186/1471-2105-8-4
   PubMedGoogle Scholar
• Fehr, A. R., Channappanavar, R., Jankevicius, G., Fett, C., Zhao, J., Athmer, J., Meyerholz, D. K., Ahel, I., & Perlman, S. (2016). The conserved coronavirus macrodomain promotes virulence and suppresses the innate immune response during severe acute respiratory syndrome coronavirus infection. mBio, 7 (6), e01721-16. https://doi.org/10.1128/mBio.01721-16
   PubMed Web of Science ®Google Scholar
• Foroutan, M., Ghaffarifar, F., Sharifi, Z., & Dalimi, A. (2020). Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. Comparative immunology, Microbiology and Infectious Diseases, 69, 101413. https://doi.org/10.1016/j.cimid.2020.101413
   PubMed Web of Science ®Google Scholar
• Freitas, B. T., Durie, I. A., Murray, J., Longo, J. E., Miller, H. C., Crich, D., Hogan, R. J., Tripp, R. A., & Pegan, S. D. (2020). Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease. ACS infectious Diseases, 6 (8), 2099–2109. https://doi.org/10.1021/acsinfecdis.0c00168
   PubMed Web of Science ®Google Scholar
• Grote, A., Hiller, K., Scheer, M., Münch, R., Nörtemann, B., Hempel, D. C., & Jahn, D. (2005). JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic acids Research, 33 (Web Server issue), W526–W531. https://doi.org/10.1093/nar/gki376
   PubMed Web of Science ®Google Scholar
• Guo, L., Yin, R., Liu, K., Lv, X., Li, Y., Duan, X., Chu, Y., Xi, T., & Xing, Y. (2014). Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model. Applied microbiology and Biotechnology, 98 (8), 3495–3507. https://doi.org/10.1007/s00253-013-5408-6
   PubMed Web of Science ®Google Scholar
• Hardenbrook, N. J., & Zhang, P. (2022). A structural view of the SARS-CoV-2 virus and its assembly. Current opinion in Virology, 52, 123–134. https://doi.org/10.1016/j.coviro.2021.11.011
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181 (2), 271–280. e8. https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Hon, J., Marusiak, M., Martinek, T., Kunka, A., Zendulka, J., Bednar, D., & Damborsky, J. (2021). SoluProt: Prediction of soluble protein expression in Escherichia coli. Bioinformatics, 37(1), 23-28. https://doi.org/10.1093/bioinformatics/btaa1102
   Web of Science ®Google Scholar
• Honorato, R. V., Koukos, P. I., Jiménez-García, B., Tsaregorodtsev, A., Verlato, M., Giachetti, A., Rosato, A., & Bonvin, A. M. (2021). Structural biology in the clouds: The WeNMR-EOSC ecosystem. Frontiers in Molecular Biosciences, 8, 729513. https://doi.org/10.3389/fmolb.2021.729513
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Ilinskaya, A. N., & Dobrovolskaia, M. A. (2016). Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future. Toxicology and Applied Pharmacology, 299, 70–77. https://doi.org/10.1016/j.taap.2016.01.005
   PubMed Web of Science ®Google Scholar
• Iwasaki, A., & Medzhitov, R. (2010). Regulation of adaptive immunity by the innate immune system. Science (New York, N.Y.), 327(5963), 291–295. https://doi.org/10.1126/science.1183021
   PubMed Web of Science ®Google Scholar
• Jabbar, B., Rafique, S., Salo-Ahen, O. M., Ali, A., Munir, M., Idrees, M., Mirza, M. U., Vanmeert, M., Shah, S. Z., & Jabbar, I. (2018). Antigenic peptide prediction from E6 and E7 oncoproteins of HPV types 16 and 18 for therapeutic vaccine design using immunoinformatics and MD simulation analysis. Frontiers in Immunology, 9, 3000. https://doi.org/10.3389/fimmu.2018.03000
   PubMed Web of Science ®Google Scholar
• Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018). Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology, 154 (3), 394–406. https://doi.org/10.1111/imm.12889
   PubMed Web of Science ®Google Scholar
• Kar, T., Narsaria, U., Basak, S., Deb, D., Castiglione, F., Mueller, D. M., & Srivastava, A. P. (2020). A candidate multi-epitope vaccine against SARS-CoV-2. Scientific reports, 10 (1), 1–24. https://doi.org/10.1038/s41598-020-67749-1
   PubMed Web of Science ®Google Scholar
• Karimi, M., Ignasiak, M. T., Chan, B., Croft, A. K., Radom, L., Schiesser, C. H., Pattison, D. I., & Davies, M. J. (2016). Reactivity of disulfide bonds is markedly affected by structure and environment: implications for protein modification and stability. Scientific Reports, 6 (1), 38572–12. https://doi.org/10.1038/srep38572
   PubMedGoogle Scholar
• Kawasaki, T., & Kawai, T. (2014). Toll-like receptor signaling pathways. Frontiers in Immunology, 5, 461. https://doi.org/10.3389/fimmu.2014.00461
   PubMed Web of Science ®Google Scholar
• Khan, S., Shafiei, M. S., Longoria, C., Schoggins, J. W., Savani, R. C., & Zaki, H. (2021). SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway. Elife, 10, e68563. https://doi.org/10.7554/eLife.68563
   PubMed Web of Science ®Google Scholar
• Kirchdoerfer, R. N., & Ward, A. B. (2019). Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature communications, 10 (1), 1–9. https://doi.org/10.1038/s41467-019-10280-3
   PubMedGoogle Scholar
• Knoops, K., Kikkert, M., Worm, S. H. V. D., Zevenhoven-Dobbe, J. C., Van Der Meer, Y., Koster, A. J., Mommaas, A. M., & Snijder, E. J. (2008). SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS biology, 6(9), e226. https://doi.org/10.1371/journal.pbio.0060226
   PubMed Web of Science ®Google Scholar
• Krogsgaard, M., & Davis, M. M. (2005). How T cells’ see’antigen. Nature Immunology, 6 (3), 239–245. https://doi.org/10.1038/ni1173
   PubMed Web of Science ®Google Scholar
• Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007). Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics, 8 (1), 1–12. https://doi.org/10.1186/1471-2105-8-424
   PubMedGoogle Scholar
• Lee, S., Channappanavar, R., & Kanneganti, T. D. (2020). Coronaviruses: Innate immunity, inflammasome activation, inflammatory cell death, and cytokines. Trends in Immunology, 41(12), 1083–1099. https://doi.org/10.1016/j.it.2020.10.005
   PubMed Web of Science ®Google Scholar
• Lennerz, V., Gross, S., Gallerani, E., Sessa, C., Mach, N., Boehm, S., Hess, D., von Boehmer, L., Knuth, A., Ochsenbein, A. F., Gnad-Vogt, U., Zieschang, J., Forssmann, U., Woelfel, T., & Kaempgen, E. (2014). Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer immunology, Immunotherapy : CII, 63 (4), 381–394. https://doi.org/10.1007/s00262-013-1516-5
   PubMed Web of Science ®Google Scholar
• Lester, S. N., & Li, K. (2014). Toll-like receptors in antiviral innate immunity. Journal of Molecular Biology, 426 (6), 1246–1264. https://doi.org/10.1016/j.jmb.2013.11.024
   PubMed Web of Science ®Google Scholar
• Li, W., Joshi, M. D., Singhania, S., Ramsey, K. H., & Murthy, A. K. (2014). Peptide vaccine: Progress and challenges. Vaccines, 2(3), 515–536. https://doi.org/10.3390/vaccines2030515
   PubMedGoogle Scholar
• Littler, D. R., MacLachlan, B. J., Watson, G. M., Vivian, J. P., & Gully, B. S. (2020). A pocket guide on how to structure SARS-CoV-2 drugs and therapies. Biochemical Society Transactions, 48 (6), 2625–2641. https://doi.org/10.1042/bst20200396
   PubMed Web of Science ®Google Scholar
• Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., Guo, X. V., Cerutti, G., Bimela, J., Gorman, J., Zhou, T., Chen, Z., Yuen, K.-Y., Kwong, P. D., Sodroski, J. G., … Ho, D. D. (2020). Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature, 584 (7821), 450–456. https://doi.org/10.1038/s41586-020-2571-7
   PubMed Web of Science ®Google Scholar
• Mahdevar, E., Kefayat, A., Safavi, A., Behnia, A., Hejazi, S. H., Javid, A., & Ghahremani, F. (2021a). Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model. Scientific Reports, 11(1), 1–13. https://doi.org/10.1038/s41598-021-01770-w
   PubMed Web of Science ®Google Scholar
• Mahdevar, E., Safavi, A., Abiri, A., Kefayat, A., Hejazi, S. H., Miresmaeili, S. M., & Iranpur Mobarakeh, V. (2021b). Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches. Journal of Biomolecular Structure and Dynamics, 40(14), 6363–6380. https://doi.org/10.1080/07391102.2021.1883111
   PubMed Web of Science ®Google Scholar
• Mariano, G., Farthing, R. J., Lale-Farjat, S. L., & Bergeron, J. R. (2020). Structural characterization of SARS-CoV-2: Where we are, and where we need to be. Frontiers in Molecular Biosciences, 7, 605236. https://doi.org/10.3389/fmolb.2020.605236
   PubMed Web of Science ®Google Scholar
• Matthews, K. L., Coleman, C. M., van der Meer, Y., Snijder, E. J., & Frieman, M. B. (2014). The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. The Journal of General Virology, 95 (Pt 4), 874. https://doi.org/10.1099/vir.0.062059-0
   PubMedGoogle Scholar
• McBride, R., Van Zyl, M., & Fielding, B. C. (2014). The coronavirus nucleocapsid is a multifunctional protein. Viruses, 6 (8), 2991–3018. https://doi.org/10.3390/v6082991
   PubMed Web of Science ®Google Scholar
• Messaoudi, A., Belguith, H., & Ben Hamida, J. (2013). Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase. Theoretical Biology and Medical Modelling, 10 (1), 1–10. https://doi.org/10.1186/1742-4682-10-22
   PubMedGoogle Scholar
• Mir, S. A., Alaidarous, M., Alshehri, B., Bin Dukhyil, A. A., Banawas, S., Madkhali, Y., Alsagaby, S. A., & Al Othaim, A. (2022). Immunoinformatics-based identification of B and T cell epitopes in RNA-dependent RNA polymerase of SARS-CoV-2. Vaccines, 10(10), 1660. https://doi.org/10.3390/vaccines10101660
   Web of Science ®Google Scholar
• Moutaftsi, M., Peters, B., Pasquetto, V., Tscharke, D. C., Sidney, J., Bui, H.-H., Grey, H., & Sette, A. (2006). A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nature biotechnology, 24 (7), 817–819. https://doi.org/10.1038/nbt1215
   PubMed Web of Science ®Google Scholar
• Nelson, M. T., Humphrey, W., Gursoy, A., Dalke, A., Kalé, L. V., Skeel, R. D., & Schulten, K. (1996). NAMD: A parallel, object-oriented molecular dynamics program. The International Journal of Supercomputer Applications and High Performance Computing, 10(4), 251–268. https://doi.org/10.1177/109434209601000401
   Web of Science ®Google Scholar
• Ojha, R., Pareek, A., Pandey, R. K., Prusty, D., & Prajapati, V. K. (2019). Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection. ACS omega, 4 (8), 13069–13079. https://doi.org/10.1021/acsomega.9b00944
   PubMed Web of Science ®Google Scholar
• Ong, E., Wong, M. U., Huffman, A., & He, Y. (2020). COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning. Frontiers in Immunology, 11, 158. https://doi.org/10.3389/fimmu.2020.01581
   PubMed Web of Science ®Google Scholar
• Palm, N. W., & Medzhitov, R. (2009). Pattern recognition receptors and control of adaptive immunity. Immunological Reviews, 227 (1), 221–233. https://doi.org/10.1111/j.1600-065x.2008.00731.x
   PubMedGoogle Scholar
• Panina‐Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G., & Lanzavecchia, A. (1989). Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. European Journal of Immunology, 19 (12), 2237–2242. https://doi.org/10.1002/eji.1830191209
   PubMed Web of Science ®Google Scholar
• Park, S. E. (2020). Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clinical and Experimental Pediatrics, 63 (4), 119–124. https://doi.org/10.3345/cep.2020.00493
   PubMedGoogle Scholar
• Peng, X.-L., Cheng, J.-S.-Y., Gong, H.-L., Yuan, M.-D., Zhao, X.-H., Li, Z., & Wei, D.-X. (2021). Advances in the design and development of SARS-CoV-2 vaccines. Military Medical Research, 8 (1), 1–31. https://doi.org/10.1186/s40779-021-00360-1
   PubMed Web of Science ®Google Scholar
• Peng, Q., Peng, R., Yuan, B., Zhao, J., Wang, M., Wang, X., Wang, Q., Sun, Y., Fan, Z., Qi, J., Gao, G. F., & Shi, Y. (2020). Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2. Cell reports, 31 (11), 107774. https://doi.org/10.1016/j.celrep.2020.107774
   PubMed Web of Science ®Google Scholar
• Phongsisay, V., Iizasa, E. i., Hara, H., & Yoshida, H. (2015). Evidence for TLR4 and FcRγ–CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors. Molecular Immunology, 66 (2), 463–471. https://doi.org/10.1016/j.molimm.2015.05.008
   PubMed Web of Science ®Google Scholar
• Piccoli, L., Park, Y.-J., Tortorici, M. A., Czudnochowski, N., Walls, A. C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L. E., Bowen, J. E., Acton, O. J., Jaconi, S., Guarino, B., Minola, A., Zatta, F., Sprugasci, N., Bassi, J., Peter, A., De Marco, A., … Veesler, D. (2020). Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell, 183 (4), 1024–1042. e21. https://doi.org/10.1016/j.cell.2020.09.037
   PubMed Web of Science ®Google Scholar
• Rapin, N., Lund, O., Bernaschi, M., & Castiglione, F. (2010). Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PloS One, 5 (4), e9862. https://doi.org/10.1371/journal.pone.0009862
   PubMed Web of Science ®Google Scholar
• Rouzbahani, A. K., Kheirandish, F., & Hosseini, S. Z. (2022). Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach. Egyptian Journal of Medical Human Genetics, 23(1), 1–18. https://doi.org/10.1186/s43042-022-00224-w
   PubMedGoogle Scholar
• Saadi, M., Karkhah, A., & Nouri, H. R. (2017). Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches. Infection, Genetics and Evolution, 51, 227–234. https://doi.org/10.1016/j.meegid.2017.04.009
   PubMed Web of Science ®Google Scholar
• Safavi, A., Kefayat, A., Abiri, A., Mahdevar, E., Behnia, A. H., & Ghahremani, F. (2019). In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology, 112, 93–102. https://doi.org/10.1016/j.molimm.2019.04.030
   PubMed Web of Science ®Google Scholar
• Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628. https://doi.org/10.1016/j.vaccine.2020.10.016
   PubMed Web of Science ®Google Scholar
• Safavi, A., Kefayat, A., Mahdevar, E., Ghahremani, F., Nezafat, N., & Modarressi, M. H. (2021). Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model. Human Vaccines & Immunotherapeutics, 17(1), 22–34. https://doi.org/10.1080/21645515.2020.1763693
   PubMed Web of Science ®Google Scholar
• Safavi, A., Kefayat, A., Sotoodehnejadnematalahi, F., Salehi, M., & Modarressi, M. H. (2019). Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine. International Immunopharmacology, 76, 105872. https://doi.org/10.1016/j.intimp.2019.105872
   PubMed Web of Science ®Google Scholar
• Safavi, A., Kefayat, A., Sotoodehnejadnematalahi, F., Salehi, M., & Modarressi, M. H. (2019). In silico analysis of synaptonemal complex protein 1 (SYCP1) and acrosin binding protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against breast cancer. International Journal of Peptide Research and Therapeutics, 25(4), 1343–1359. https://doi.org/10.1007/s10989-018-9780-z
   Web of Science ®Google Scholar
• Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010). FOXP3+ regulatory T cells in the human immune system. Nature Reviews. Immunology, 10 (7), 490–500. https://doi.org/10.1038/nri2785
   PubMed Web of Science ®Google Scholar
• Sawicki, S. G., Sawicki, D. L., & Siddell, S. G. (2007). A contemporary view of coronavirus transcription. Journal of Virology, 81(1), 20–29. https://doi.org/10.1128/JVI.01358-06
   PubMed Web of Science ®Google Scholar
• Sette, A., & Crotty, S. (2021). Adaptive immunity to SARS-CoV-2 and COVID-19. Cell, 184(4), 861–880. https://doi.org/10.1016/j.cell.2021.01.007
   PubMed Web of Science ®Google Scholar
• Shankar, U., Jain, N., Mishra, S. K., Sk, M. F., Kar, P., & Kumar, A. (2021). Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection. Journal of Biomolecular Structure and Dynamics, 40(11), 1–17. https://doi.org/10.1080/07391102.2021.1874529
   Web of Science ®Google Scholar
• Shilling, P. J., Mirzadeh, K., Cumming, A. J., Widesheim, M., Köck, Z., & Daley, D. O. (2020). Improved designs for pET expression plasmids increase protein production yield in Escherichia coli. Communications biology, 3(1), 1–8. https://doi.org/10.1038/s42003-020-0939-8
   PubMed Web of Science ®Google Scholar
• Singh, G., Pritam, M., Banerjee, M., Singh, A. K., & Singh, S. P. (2020). Designing of precise vaccine construct against visceral leishmaniasis through predicted epitope ensemble: A contemporary approach. Computational Biology and Chemistry, 86, 107259. https://doi.org/10.1016/j.compbiolchem.2020.107259
   PubMed Web of Science ®Google Scholar
• Slingluff, C. L., Lee, S., Zhao, F., Chianese-Bullock, K. A., Olson, W. C., Butterfield, L. H., Whiteside, T. L., Leming, P. D., & Kirkwood, J. M. (2013). A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602). Clinical Cancer Research, 19 (15), 4228–4238. https://doi.org/10.1158/1078-0432.ccr-13-0002
   PubMed Web of Science ®Google Scholar
• Stratmann, T. (2015). Cholera toxin subunit B as adjuvant––an accelerator in protective immunity and a break in autoimmunity. Vaccines, 3 (3), 579–596. https://doi.org/10.3390/vaccines3030579
   PubMedGoogle Scholar
• Sun, Y., Koh, V., Marimuthu, K., Ng, O. T., Young, B., Vasoo, S., Chan, M., Lee, V. J. M., De, P. P., Barkham, T., Lin, R. T. P., Cook, A. R., & Leo, Y. S. (2020). Epidemiological and clinical predictors of COVID-19. Clinical Infectious Diseases, 71 (15), 786–792. https://doi.org/10.1093/cid/ciaa322
   PubMed Web of Science ®Google Scholar
• Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., & Wang, E. (2021). Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell Reports Medicine, 2 (7), 100355. https://doi.org/10.1016/j.xcrm.2021.100355
   PubMedGoogle Scholar
• Testa, J. S., & Philip, R. (2012). Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications. Future Virology, 7 (11), 1077–1088. https://doi.org/10.2217/fvl.12.108
   PubMed Web of Science ®Google Scholar
• Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., & Ziebuhr, J. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84(Pt 9), 2305–2315. https://doi.org/10.1099/vir.0.19424-0
   PubMed Web of Science ®Google Scholar
• Tortorici, M. A., Beltramello, M., Lempp, F. A., Pinto, D., Dang, H. V., Rosen, L. E., McCallum, M., Bowen, J., Minola, A., Jaconi, S., Zatta, F., De Marco, A., Guarino, B., Bianchi, S., Lauron, E. J., Tucker, H., Zhou, J., Peter, A., Havenar-Daughton, C., … Veesler, D. (2020). Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science (New York, N.Y.), 370 (6519), 950–957. https://doi.org/10.1126/science.abe3354
   PubMed Web of Science ®Google Scholar
• Tosta, S. F. D. O., Passos, M. S., Kato, R., Salgado, Á., Xavier, J., Jaiswal, A. K., Soares, S. C., Azevedo, V., Giovanetti, M., Tiwari, S., & Alcantara, L. C. J. (2021). Multi-epitope based vaccine against yellow fever virus applying immunoinformatics approaches. Journal of Biomolecular Structure and Dynamics, 39(1), 219–235. https://doi.org/10.1080/07391102.2019.1707120
   PubMed Web of Science ®Google Scholar
• Turner, P., & Xmgrace, V. (2005). 5.1.19. Center for Coastal and Land-Margin Research. Oregon Graduate Institute of Science and Technology. 2.
   Google Scholar
• Vangone, A., Schaarschmidt, J., Koukos, P., Geng, C., Citro, N., Trellet, M. E., Xue, L. C., & Bonvin, A. M. (2019). Large-scale prediction of binding affinity in protein–small ligand complexes: The PRODIGY-LIG web server. Bioinformatics (Oxford, England), 35 (9), 1585–1587. https://doi.org/10.1093/bioinformatics/bty816
   PubMed Web of Science ®Google Scholar
• Wahome, N., Pfeiffer, T., Ambiel, I., Yang, Y., Keppler, O. T., Bosch, V., & Burkhard, P. (2012). Conformation‐specific display of 4E10 and 2F5 epitopes on self‐assembling protein nanoparticles as a potential HIV vaccine. Chemical Biology & Drug Design, 80(3), 349–357. https://doi.org/10.1111/j.1747-0285.2012.01423.x
   PubMed Web of Science ®Google Scholar
• Walker, J. M. (2005). The proteomics protocols handbook. Springer.
   Google Scholar
• Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181 (2), 281–292. e6. https://doi.org/10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35 (Web Server issue), W407–W410. https://doi.org/10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S., & Richardson, D. C. (2018). MolProbity: More and better reference data for improved all‐atom structure validation. Protein Science, 27 (1), 293–315. https://doi.org/10.1002/pro.3330
   PubMed Web of Science ®Google Scholar
• Yadav, R., Chaudhary, J. K., Jain, N., Chaudhary, P. K., Khanra, S., Dhamija, P., Sharma, A., Kumar, A., & Handu, S. (2021). Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells, 10 (4), 821. https://doi.org/10.3390/cells10040821
   PubMed Web of Science ®Google Scholar
• Yang, J., Anishchenko, I., Park, H., Peng, Z., Ovchinnikov, S., & Baker, D. (2020). Improved protein structure prediction using predicted interresidue orientations. Proceedings of the National Academy of Sciences of the United States of America, 117 (3), 1496–1503. https://doi.org/10.1073/pnas.1914677117
   PubMed Web of Science ®Google Scholar
• Yoshimoto, F. K. (2020). The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. The Protein Journal, 39 (3), 198–216. https://doi.org/10.1007/s10930-020-09901-4
   PubMed Web of Science ®Google Scholar
• Zhang, L. (2018). Multi-epitope vaccines: a promising strategy against tumors and viral infections. Cellular & Molecular Immunology, 15 (2), 182–184. https://doi.org/10.1038/cmi.2017.92
   PubMed Web of Science ®Google Scholar
• Zhao, Y., Kuang, M., Li, J., Zhu, L., Jia, Z., Guo, X., Hu, Y., Kong, J., Yin, H., Wang, X., & You, F. (2021). SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Research, 31 (7), 818–820. https://doi.org/10.1038/s41422-021-00495-9
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Zhu, S., Feng, Y., Rao, P., Xue, X., Chen, S., Li, W., Zhu, G., & Zhang, L. (2014). Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice. Applied microbiology and Biotechnology, 98(9), 4107–4117. https://doi.org/10.1007/s00253-014-5517-x
   PubMed Web of Science ®Google Scholar